Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans (Q35527215)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 February 2015
edit
Language Label Description Also known as
English
Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans
scientific article published on 26 February 2015

    Statements

    Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans (English)
    0 references
    0 references
    0 references
    Sandeep Golegaonkar
    Syed S Tabrez
    Awadhesh Pandit
    Sneha Bansode
    Mahesh J Kulkarni
    26 February 2015

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit